Use of PRKO mice to study the role of progesterone in mammary gland development

RC Humphreys, JP Lydon, BW O'Malley… - Journal of mammary …, 1997 - Springer
To better understand the distinct physiological roles played by progesterone and estrogen
receptors (PR amd ER) 4 as well as to study directly PR function in an in vivo context, a novel …

Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis

RC Humphreys, M Krajewska, S Krnacik… - …, 1996 - journals.biologists.com
Ductal morphogenesis in the rodent mammary gland is characterized by the rapid
penetration of the stromal fat pad by the highly proliferative terminal endbud and sub-sequent …

Transforming growth factor alpha and mouse models of human breast cancer

RC Humphreys, L Hennighausen - Oncogene, 2000 - nature.com
Transforming growth factor alpha (TGFα) is a principal molecule in the normal and neoplastic
development of the mammary gland. Binding of TGFα to the epidermal growth factor …

Mammary gland development is mediated by both stromal and epithelial progesterone receptors

RC Humphreys, J Lydon, BW O'Malley… - Molecular …, 1997 - academic.oup.com
… ability (43), although the properties defined in these in vitro assays do not always
correspond to their effects in vivo (RC Humphreys and JM Rosen, submitted for publication). …

Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli

RC Humphreys, B Bierie, L Zhao, R Raz, D Levy… - …, 2002 - academic.oup.com
The transcription factor Stat3 is activated through tyrosine phosphorylation by many
cytokines and is a fundamental mediator of their signals. In the mammary gland, Stat3 activity …

Trail receptors: targets for cancer therapy

RC Humphreys, W Halpern - Advances in experimental medicine and …, 2008 - Springer
A human tumor cell’s ability to avoid the normal regulatory mechanisms of cell growth, division,
and death are the hallmarks of transformation and cancer. Numerous novel therapeutic …

Phase II Trial of Mapatumumab, a fully human agonist monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1), in …

…, M Dediu, M Reck, CL Cebotaru, RC Humphreys… - Clinical lung cancer, 2014 - Elsevier
Background This phase II study examined the efficacy of mapatumumab in combination with
paclitaxel and carboplatin in patients with non–small-cell lung cancer (NSCLC). Patients …

Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis

RC Humphreys, L Hennighausen - 1999 - AACR
The mammary gland undergoes extensive tissue remodeling and cell death at the end of
lactation in a process known as involution. We present evidence that the prolactin-activated …

Localization and quantification of Wnt-2 gene expression in mouse mammary development

TA Bühler, TC Dale, C Kieback, RC Humphreys… - Developmental …, 1993 - Elsevier
The Wnt gene family encodes a group of proteins probably involved in cell-cell communication
during several stages of vertebrate development. More than 10 members of this family …

Site specific conjugation of ARX-788, an antibody drug conjugate (ADC) targeting HER2, generates a potent and stable targeted therapeutic for multiple cancers

RC Humphreys, J Kirtely, A Hewit, S Biroc, N Knudsen… - Cancer Research, 2015 - AACR
Creation of ADCs by conjugating drug linkers and toxin payloads to available native lysines
or cysteines generates ADCs with highly variable drug to antibody loading and linker …